Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,800 | 294 | 68.3% |
| Consulting Fee | $1,050 | 3 | 18.9% |
| Honoraria | $500.00 | 1 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 3.6% |
| Education | $14.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | $1,111 | 31 | $0 (2019) |
| Encore Dermatology Inc. | $931.09 | 14 | $0 (2019) |
| PFIZER INC. | $492.15 | 49 | $0 (2024) |
| Galderma Laboratories, L.P. | $439.39 | 35 | $0 (2024) |
| ABBVIE INC. | $389.12 | 24 | $0 (2024) |
| Promius Pharma LLC | $242.49 | 17 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $193.93 | 7 | $0 (2023) |
| LEO Pharma Inc. | $182.07 | 21 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $179.45 | 14 | $0 (2022) |
| Janssen Biotech, Inc. | $174.13 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $359.93 | 21 | Janssen Biotech, Inc. ($86.29) |
| 2023 | $536.02 | 33 | ABBVIE INC. ($104.14) |
| 2022 | $139.21 | 9 | ABBVIE INC. ($41.02) |
| 2021 | $105.28 | 7 | LEO Pharma Inc. ($28.51) |
| 2020 | $87.56 | 6 | PFIZER INC. ($26.35) |
| 2019 | $1,091 | 56 | Medimetriks Pharmaceuticals, Inc. ($350.00) |
| 2018 | $1,874 | 94 | Encore Dermatology Inc. ($675.63) |
| 2017 | $1,371 | 74 | Medimetriks Pharmaceuticals, Inc. ($406.08) |
All Payment Transactions
300 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Immunology | ||||||
| 06/28/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
| 06/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Dermatology | ||||||
| 05/24/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: Dermatology | ||||||
| 03/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 03/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: DERMATOLOGY | ||||||
| 01/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Dermatology | ||||||
| 12/20/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 11/02/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 11/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,017 | 1,962 | $430,797 | $98,803 |
| 2022 | 13 | 811 | 1,378 | $320,242 | $78,123 |
| 2021 | 13 | 748 | 1,274 | $204,988 | $74,185 |
| 2020 | 12 | 641 | 1,125 | $173,752 | $54,716 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 306 | $91,901 | $21,550 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 175 | $73,470 | $17,738 | 24.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 119 | 180 | $72,694 | $17,063 | 23.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 136 | 231 | $54,230 | $10,520 | 19.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 87 | 97 | $34,616 | $7,697 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 105 | 157 | $29,896 | $6,923 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $20,720 | $4,931 | 23.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 93 | 621 | $14,907 | $3,773 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $13,879 | $3,036 | 21.9% |
| 10040 | Acne surgery | Office | 2023 | 22 | 28 | $11,270 | $2,680 | 23.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 32 | $5,637 | $1,474 | 26.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $4,902 | $905.47 | 18.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 13 | $2,598 | $494.92 | 19.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 22 | $77.94 | $18.68 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 179 | 257 | $73,477 | $18,017 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 140 | $57,003 | $14,982 | 26.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 85 | 126 | $48,074 | $12,338 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 102 | 154 | $34,583 | $7,722 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 93 | 132 | $24,769 | $6,307 | 25.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 75 | 81 | $27,871 | $5,978 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $17,268 | $4,090 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $9,831 | $2,380 | 24.2% |
| 10040 | Acne surgery | Office | 2022 | 19 | 21 | $7,812 | $2,105 | 26.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 57 | 322 | $8,918 | $1,965 | 22.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 16 | 31 | $5,442 | $1,485 | 27.3% |
About Dr. Amy Freeman, MD
Dr. Amy Freeman, MD is a Specialist healthcare provider based in Millburn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467448514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Freeman, MD has received a total of $5,564 in payments from pharmaceutical and medical device companies, with $359.93 received in 2024. These payments were reported across 300 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,800).
As a Medicare-enrolled provider, Freeman has provided services to 3,217 Medicare beneficiaries, totaling 5,739 services with total Medicare billing of $305,827. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Millburn, NJ
- Active Since 09/23/2005
- Last Updated 02/18/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1467448514
Products in Payments
- Impoyz (Drug) $701.79
- EUCRISA (Drug) $492.15
- Genadur Kit (Drug) $350.00
- Nicadan (Drug) $350.00
- EPIDUO FORTE (Drug) $208.30
- Humira (Biological) $183.57
- VTAMA (Drug) $132.58
- ENSTILAR (Drug) $130.67
- Cloderm Cream (Drug) $127.99
- KERYDIN (Drug) $126.23
- DUPIXENT (Biological) $110.60
- SKYRIZI (Biological) $100.01
- Otezla (Drug) $98.83
- RINVOQ (Biological) $89.24
- TREMFYA (Drug) $86.29
- COSENTYX (Biological) $84.55
- BRYHALI (Drug) $82.02
- TALTZ (Drug) $77.70
- Sernivo Spray 120ml (Drug) $74.89
- ORACEA (Drug) $70.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Millburn
Dr. Matan Yemini, Md, MD
Specialist — Payments: $1,832
John Manicone
Specialist — Payments: $916.54
Dr. Lonnie Hanauer, M.d, M.D
Specialist — Payments: $166.29
Dr. Arie Birkenfeld, M.d, M.D
Specialist — Payments: $100.34
Richard Stillman, M.d, M.D
Specialist — Payments: $81.64
Dr. Jacquelyn Dix, M.d, M.D
Specialist — Payments: $33.04